There is growing scientific, clinical, commercial and regulatory recognition that enantiomers offer benefits over racemates in the management of psychiatric diseases as well as in clinical medicine generally. However, relatively few studies consider enantiomers' individual characteristics. This revi
An introduction to the ‘enantiomer debate’
✍ Scribed by J. Caldwell; B. E. Leonard
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 27 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.340
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Psychopharmacology, and the treatment of depression in particular, is one area where there is currently an increasing awareness of chiral drug phenomena. It is now generally agreed that the pharmacological and pharmacokinetic properties of chiral drugs and their enantiomers should be assessed early
This review uses several examples drawn from the literature to show how using active enantiomers as therapeutic agents may yield several benefits, including more predictable pharmacokinetics, more accurate drug monitoring and enhanced tolerability. As a result of these benefits, the therapeutic use
As a new feature, Deuelopmental Psychobiology will publish Letters to the Editor that discuss material published in the journal and issues of general interest to the readership. Letters discussing material published in Developmental Psychobiology may correct errors, offer clarification, provide supp